{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:34:30Z","timestamp":1761762870884},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/bf02967633","type":"journal-article","created":{"date-parts":[[2008,10,7]],"date-time":"2008-10-07T06:54:48Z","timestamp":1223362488000},"page":"97-104","source":"Crossref","is-referenced-by-count":19,"title":["Significance of immunohistochemical assessment of steroid hormone receptor status for breast cancer patients"],"prefix":"10.1007","volume":"10","author":[{"given":"Masafumi","family":"Kurosumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02967633_CR1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","volume":"351","author":"Group EBCTC","year":"1998","unstructured":"Group EBCTC: Tamoxifen for early breast cancer. An overview of the randomized trials.Lancet 351: 1451\u20131467, 1998.","journal-title":"Lancet"},{"key":"BF02967633_CR2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF02966451","volume":"6","author":"H Sonoo","year":"1999","unstructured":"Sonoo H, Kurebayashi J, Iino Y, Inaji H, Watanabe T, Toi M, Kobayashi S, Sato B, Yoshimoto M: Current status and controversial issues concerning endocrine therapy in patients with recurrent breast cancer in Japan.Breast Cancer 6: 344\u2013350, 1999.","journal-title":"Breast Cancer"},{"key":"BF02967633_CR3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/1097-0142(19910815)68:4<867::AID-CNCR2820680432>3.0.CO;2-H","volume":"68","author":"WR Bezwoda","year":"1991","unstructured":"Bezwoda WR, Esser JD, Dansey R, Kessel I, Lange M: The value of estrogen and progesterone receptor determinations in advanced breast cancer.Cancer 68: 867\u2013872, 1991.","journal-title":"Cancer"},{"key":"BF02967633_CR4","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1002\/1097-0142(19801215)46:12+<2838::AID-CNCR2820461421>3.0.CO;2-A","volume":"46","author":"A Manni","year":"1980","unstructured":"Manni, A, Arafah B, Pearson OH: Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy.Cancer 46: 2838\u20132841, 1980.","journal-title":"Cancer"},{"key":"BF02967633_CR5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/bjc.1992.153","volume":"65","author":"JF Robertson","year":"1992","unstructured":"Robertson JF, Bates K, Pearson D, Blammy KW, Nicholsen RI: Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.Br J Cancer 65: 727\u2013730, 1992.","journal-title":"Br J Cancer"},{"key":"BF02967633_CR6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1200\/JCO.1992.10.8.1284","volume":"10","author":"PM Ravdin","year":"1992","unstructured":"Ravdin PM, Green S, Dorr TM, McGuire WL, Fobian C, Pugh RP, Carlor RD, Rivkin SE, Borst JR, Bolt RJ: Prognostic significance of progesterone receptor levels in estrogen-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.J Clin Oncol 10: 1284\u20131291, 1992.","journal-title":"J Clin Oncol"},{"key":"BF02967633_CR7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.1998.16.2.453","volume":"16","author":"P Dombernowsky","year":"1998","unstructured":"Dombernowsky P, Smith I, Falkson G, Leonard R, Panasci L, Bellmunt J, Bezwoda W, Gardin G, Gudgeon A, Morgan M, Fornasiero A, Hoffmann W, Michel J, Hatschek T, Tjabbes T, Chaudri HA, Horn-berger U, Trunet PF: Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.J Clin Oncol 16: 453\u2013456, 1998.","journal-title":"J Clin Oncol"},{"key":"BF02967633_CR8","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1200\/JCO.1996.14.7.2000","volume":"14","author":"A Butzdar","year":"1996","unstructured":"Butzdar A, Jonat W, Howell A, Blomqvist C, Vogel CL, Eiermann W, Wolter JM, Azab M, Webster A, Plourde PV: Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal woman with advanced breast cancer: results of overview analysis of two phase III trials.J Clin Oncol 14: 2000\u20132011, 1996.","journal-title":"J Clin Oncol"},{"key":"BF02967633_CR9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-2964(80)90348-5","volume":"16","author":"JC Allegra","year":"1980","unstructured":"Allegra JC, Lippan MC, Thompson EB, Simon R, Bar-lock A, Green L, Huff KK, Do HM, Aitken SC, Warren R: Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer.Eur J Cancer 16: 323\u2013331, 1980.","journal-title":"Eur J Cancer"},{"key":"BF02967633_CR10","first-page":"4233s","volume":"46","author":"G Leclercq","year":"1986","unstructured":"Leclercq G, Bojar H, Goussard J, Nicholson RI, Pichon MF, Piffanelli A, Pousette A, Thorpe S, Lons-dorfer M: Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.Cancer Res 46: 4233s-4236s, 1986.","journal-title":"Cancer Res"},{"key":"BF02967633_CR11","first-page":"59","volume":"7","author":"CR Taylor","year":"1994","unstructured":"Taylor CR: The current role of immunohistochemistry in diagnostic pathology.Adv Pathol Lab Med 7: 59\u2013105, 1994.","journal-title":"Adv Pathol Lab Med"},{"key":"BF02967633_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0022-4731(84)90188-2","volume":"20","author":"GL Greene","year":"1984","unstructured":"Greene GL, Sobel NB, King WJ, Jensen EV: Immunohistochemical studies of estrogen receptors.J Steroid Biochem 20: 51\u201356, 1984.","journal-title":"J Steroid Biochem"},{"key":"BF02967633_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1524-4741.2000.99097.x","volume":"6","author":"LJ Layfield","year":"2000","unstructured":"Layfield LJ, Gupta D, Mooney EE: Assessment of tissue estrogen and progesterone receptor levels: a survey of current practice, techniques, and quantitation methods.Breast J 6: 189\u2013196, 2000.","journal-title":"Breast J"},{"key":"BF02967633_CR14","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2001.19.18.3817","volume":"19","author":"A Goldhirsch","year":"2001","unstructured":"Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ: Meeting highlights: International consensus panel on the treatment of primary breast cancer.J Clin Oncol 19: 3817\u20133827, 2001.","journal-title":"J Clin Oncol"},{"key":"BF02967633_CR15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(01)72307-0","volume":"2","author":"GT Beatson","year":"1896","unstructured":"Beatson GT: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases.Lancet 2: 104, 1896.","journal-title":"Lancet"},{"key":"BF02967633_CR16","first-page":"693","volume":"46","author":"Y Nomura","year":"2000","unstructured":"Nomura Y: Recent Progress in endocrine therapy for breast cancer.Jpn J Cancer Clin 46: 693\u2013700, 2000.","journal-title":"Jpn J Cancer Clin"},{"key":"BF02967633_CR17","first-page":"87","volume":"8","author":"YM Chen","year":"1986","unstructured":"Chen YM, Gertz KR, Vaughn CB: Assay of ER and PgR in the presence of molybdate.Breast Cancer Res Treat 8: 87, 1986.","journal-title":"Breast Cancer Res Treat"},{"key":"BF02967633_CR18","first-page":"701","volume":"46","author":"H Sonoo","year":"2000","unstructured":"Sonoo H: Adjuvant hormone therapy for breast cancer.Jpn J Cancer Clin 46: 701\u2013709, 2000.","journal-title":"Jpn J Cancer Clin"},{"key":"BF02967633_CR19","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/1097-0142(197705)39:5<1971::AID-CNCR2820390510>3.0.CO;2-8","volume":"39","author":"JC Heuson","year":"1977","unstructured":"Heuson JC, Longeval E, Mattheiem WH, Deboel MC, Syvester RJ, Leccclercq G: Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced brest cancer.Cancer 39: 1971\u20131977, 1977.","journal-title":"Cancer"},{"key":"BF02967633_CR20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(81)91341-6","volume":"2","author":"FC Campbell","year":"1981","unstructured":"Campbell FC, Blarney RW, Elston CW, Morris AH, Nicholson RI, Griffiths K, Haybittle JL: Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy.Lancet 2: 1317\u20131319, 1981.","journal-title":"Lancet"},{"key":"BF02967633_CR21","first-page":"244","volume":"48","author":"M Kurosumi","year":"1998","unstructured":"Kurosumi M, Kusawake T, Takeo K, Suemasu K, Higashi Y: Assessment of estrogen receptor (ER) by immunohistochemistry in resected breast cancer tissues after breast-conserving surgery.Kitakanto Med J 48: 244, 1998 (Proceeding of 23th Saitama and Gunma Conference of Breast Disease, in Japanese).","journal-title":"Kitakanto Med J"},{"key":"BF02967633_CR22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/002215549704500301","volume":"45","author":"S-R Shi","year":"1997","unstructured":"Shi S-R, Cote RJ, Taylor CR: Antigen retrieval immunohistochemistry: past, present, and future.J Histochem Cytochem 45: 327\u2013343, 1997.","journal-title":"J Histochem Cytochem"},{"key":"BF02967633_CR23","first-page":"558","volume":"15","author":"K Suemasu","year":"2000","unstructured":"Suemasu K, Kurosumi M, Sakamoto G: Risk factors for local recurrence (especially inflammatory recurrence) of breast cancer after breast-conserving surgery.Jpn J Breast Cancer 15: 558\u2013566, 2000.","journal-title":"Jpn J Breast Cancer"},{"key":"BF02967633_CR24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0277-5379(98)90006-2","volume":"24","author":"J Andersen","year":"1988","unstructured":"Andersen J, Bentzen SM, Poulsen HS: Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation.Eur J Cancer Clin Oncol 24: 377\u2013384, 1988.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF02967633_CR25","first-page":"716","volume":"109","author":"KS McCarty","year":"1985","unstructured":"McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KS: Estrogen receptor analysis. Correlation of biochemical and immunohistochemical methods using monoclonal immunohistochemical and biochemical methods.Arch Pathol Lab Med 109: 716\u2013721, 1985.","journal-title":"Arch Pathol Lab Med"},{"key":"BF02967633_CR26","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0277-5379(89)90100-4","volume":"25","author":"G Sondergaard","year":"1989","unstructured":"Sondergaard G, Pedersen KO, Paulsen SM: Estrogen receptor analyses in breast cancer: comparison of monoclonal immunohistochemical and biochemical methods.Eur J Cancer Clin Oncol 25: 1425\u20131429, 1989.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF02967633_CR27","first-page":"1052","volume":"49","author":"LB Kinsel","year":"1989","unstructured":"Kinsel LB, Szabo E, Greene GL, Konrath J, Leight GS, McCarry KS: Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods.Cancer Res 49: 1052\u20131056, 1989.","journal-title":"Cancer Res"},{"key":"BF02967633_CR28","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/1097-0142(19901015)66:8<1663::AID-CNCR2820660802>3.0.CO;2-C","volume":"66","author":"LP Pertschuk","year":"1990","unstructured":"Pertschuk LP, Kim DS, Nayer K, Feldman JG, Eisen-berg KB, Carter AC, Rong ZT, Thelmo WL, Fleisher J, Greene GL: Immnocytochemical estrogen and progesterone receptor assays in breast cancer with monoclonal antibodies: histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival.Cancer 66: 1663\u20131670, 1990.","journal-title":"Cancer"},{"key":"BF02967633_CR29","first-page":"275","volume":"1","author":"DL Kell","year":"1993","unstructured":"Kell DL, Kamel OW, Rouse RV: Immunohistochemical analysis of breast carcinoma estrogen and progesterone receptors in paraffin-embedded tissue. Correlation of clones ERID5 and IA6 with a cytosol-based hormone receptor assay.Appl Immunobiochem 1: 275\u2013281, 1993.","journal-title":"Appl Immunobiochem"},{"key":"BF02967633_CR30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ajcp\/99.1.32","volume":"99","author":"JM Esteban","year":"1993","unstructured":"Esteban JM, Kandalaft PL, Mehta P, Odem-Maryon TL, Bacus S, Battifora H: Improvement on the quantification of estrogen and progesterone receptors on paraffin-embedded tumors by image analysis.Am J Clin Pathol 99: 32\u201338, 1993.","journal-title":"Am J Clin Pathol"},{"key":"BF02967633_CR31","first-page":"3752","volume":"54","author":"RM Elledge","year":"1994","unstructured":"Elledge, RM, Clark GM, Fuqua SAW, Allred DC:P53 protein accumulation detected by five different abtibodies: relationship to prognosis and heat shock protein 70 in breast cancer.Cancer Res 54: 3752\u20133757, 1994.","journal-title":"Cancer Res"},{"key":"BF02967633_CR32","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","volume":"17","author":"JM Harvey","year":"1999","unstructured":"Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.J Clin Oncol 17: 1474\u20131481, 1999.","journal-title":"J Clin Oncol"},{"key":"BF02967633_CR33","first-page":"581","volume":"8","author":"M Kurosumi","year":"1993","unstructured":"Kurosumi M, Kishi K, Takayama S, Kano T, Kurihara T, Suemasu K, Higashi Y: Histopathological examination of carcinoma involvement around surgical margins in the resected specimen of breast conservative surgery.Jpn J Breast Cancer 8: 581\u2013586, 1993.","journal-title":"Jpn J Breast Cancer"},{"key":"BF02967633_CR34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1677\/erc.0.0060227","volume":"6","author":"JM Dixon","year":"1999","unstructured":"Dixon JM, Love CDB, Renshaw L, Cameron DA, Miller WR, Leonard RC: Lessons from the use of aromatase inhibitors in the neoadjuvant setting.Endocrine-Related Cancer 6: 227\u2013230, 1999.","journal-title":"Endocrine-Related Cancer"},{"key":"BF02967633_CR35","first-page":"2229","volume":"6","author":"JM Dixon","year":"2000","unstructured":"Dixon JM, Renshaw L, Bellamy C, Stuart M, Hoctin-Boes G, Miller WR: The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study.Clin Cancer Res 6: 2229\u20132235, 2000.","journal-title":"Clin Cancer Res"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02967633.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02967633\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02967633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T21:11:27Z","timestamp":1558473087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02967633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["BF02967633"],"URL":"https:\/\/doi.org\/10.1007\/bf02967633","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}